StockData
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. (IDYA) stock

IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/303% above fair value
$27.40−2.96 (-9.75%)

Close on Nov 17, 2026Market cap $2.64BP/E –Yield –

IDEAYA Biosciences total assets

Total assets on the balance sheet at the end of each period.

IDEAYA Biosciences's total assets was $1.31B at Jun 30, 2026. For fiscal 2025 it was $1.11B, down 1.3% from the year before. The highest annual figure on record is $1.12B in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.11B-1.3%
FY2024Dec 31, 2024$1.12B+73.1%
FY2023Dec 31, 2023$649.32M+67.4%
FY2022Dec 31, 2022$387.97M+1.7%
FY2021Dec 31, 2021$381.35M+27.9%
FY2020Dec 31, 2020$298.27M+164.0%
FY2019Dec 31, 2019$113.00M+17.0%
FY2018Dec 31, 2018$96.54M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.31B+25.8%
Q1 FY2026Mar 31, 2026$1.03B-6.4%
Q4 FY2025Dec 31, 2025$1.11B-1.3%
Q3 FY2025Sep 30, 2025$1.19B-4.4%
Q2 FY2025Jun 30, 2025$1.04B+6.9%
Q1 FY2025Mar 31, 2025$1.10B+14.5%
Q4 FY2024Dec 31, 2024$1.12B+73.1%
Q3 FY2024Sep 30, 2024$1.24B+132.6%
Q2 FY2024Jun 30, 2024$973.66M+84.6%
Q1 FY2024Mar 31, 2024$961.53M+163.6%
Q4 FY2023Dec 31, 2023$649.32M+67.4%
Q3 FY2023Sep 30, 2023$532.94M+29.7%
Q2 FY2023Jun 30, 2023$527.56M+56.1%
Q1 FY2023Mar 31, 2023$364.75M+1.6%
Q4 FY2022Dec 31, 2022$387.97M+1.7%
Q3 FY2022Sep 30, 2022$410.91M+2.9%
Q2 FY2022Jun 30, 2022$338.01M+2.9%
Q1 FY2022Mar 31, 2022$358.87M+10.0%
Q4 FY2021Dec 31, 2021$381.35M+27.9%
Q3 FY2021Sep 30, 2021$399.44M+32.5%
Q2 FY2021Jun 30, 2021$328.40M+78.0%
Q1 FY2021Mar 31, 2021$326.10M+220.4%
Q4 FY2020Dec 31, 2020$298.27M+164.0%
Q3 FY2020Sep 30, 2020$301.38M+146.4%
Q2 FY2020Jun 30, 2020$184.51M+38.4%
Q1 FY2020Mar 31, 2020$101.79M+5.4%
Q4 FY2019Dec 31, 2019$113.00M–
Q3 FY2019Sep 30, 2019$122.33M–
Q2 FY2019Jun 30, 2019$133.36M–
Q4 FY2018Dec 31, 2018$96.54M–

More IDEAYA Biosciences figures

See a number that looks wrong?